Results 121 to 130 of about 115,545 (228)

Systemic Alterations in Type-2 Conventional Dendritic Cells Lead to Impaired Tumor Immunity in Pancreatic Cancer. [PDF]

open access: yesCancer Immunol Res, 2023
James CA   +15 more
europepmc   +1 more source

Mesoporous Silica Nanoparticles in Biomedicine: Advances and Prospects

open access: yesAdvanced Materials, EarlyView.
Mesoporous silica nanoparticles offer unique properties like high surface area, tunable pores, and functionalization. They excel in drug delivery, tissue engineering, and stimuli‐responsive therapies, enabling targeted and controlled treatments. With roles in cancer therapy and diagnostics, their clinical translation requires addressing challenges in ...
Miguel Manzano, María Vallet‐Regí
wiley   +1 more source

Complement C1q essential for aeroallergen sensitization via CSF1R<sup>+</sup> conventional dendritic cells type 2. [PDF]

open access: yesJ Allergy Clin Immunol, 2023
Moon HG   +15 more
europepmc   +1 more source

Azaporphyrinoid‐Based Photo‐ and Electroactive Architectures for Advanced Functional Materials

open access: yesAdvanced Materials, EarlyView.
A long‐standing collaboration between the Torres and Guldi groups has yielded diverse azaporphyrinoid‐based donor‐acceptor nanohybrids with promising applications in solar energy conversion. This conspectus highlights key molecular platforms and structure‐function relationships that govern light and charge management, supporting the rational design of ...
Jorge Labella   +3 more
wiley   +1 more source

Type 1 conventional dendritic cells in kidney disease

open access: yes, 2021
Dendritic cells (DCs) are central orchestrators of the immune system, which regulate both innate and adaptive immune responses. They can be broadly categorized into plasmacytoid DCs (pDCs) and conventional DCs (cDCs). cDC1s are a major subset of conventional DCs and play an important role in kidney disease.
openaire   +1 more source

Cold Atmospheric Plasma‐Activated Decellularized Extracellular Matrix Gel as a Tumor‐Infiltrating Immunoactivation Platform for Post‐Surgical Cancer Immunotherapy

open access: yesAdvanced Materials, EarlyView.
An injectable cold atmospheric plasma‐activated decellularized tumor extracellular matrix hydrogel is introduced as a post‐surgical immunoactivation platform. The engineered gel attracts residual tumor cells and induces immunogenic cell death, reshaping the tumor microenvironment and eliciting systemic antitumor immunity. In combination with checkpoint
Tianxu Fang   +5 more
wiley   +1 more source

Single cell RNA sequencing reveals distinct clusters of Irf8-expressing pulmonary conventional dendritic cells. [PDF]

open access: yesFront Immunol, 2023
Jirmo AC   +11 more
europepmc   +1 more source

Remote‐Controllable Immune‐Priming Spot Formation Via Nanocomplexed Hydrogel‐Assisted Histotripsy: Immunoasis

open access: yesAdvanced Materials, EarlyView.
A novel immunotherapeutic strategy combines injectable, adjuvant‐loaded hydrogels with externally controlled histotripsy to create immune‐priming sites within tumors. This approach generates millimeter‐sized immune‐activated lesions with flexible, patient‐tailored treatment scheduling, enabling precise immune activation through tumor ablation‐mediated ...
Sung Hoon Kim   +9 more
wiley   +1 more source

STAT3 Inhibits Autocrine IFN Signaling in Type I Conventional Dendritic Cells. [PDF]

open access: yesJ Immunol, 2022
Chrisikos TT   +8 more
europepmc   +1 more source

Decoding NASICON and Its Metal Interface for Solid‐State Batteries

open access: yesAdvanced Materials, EarlyView.
This review paper focuses on lithium‐ and sodium‐based NASICON solid electrolytes and their interfaces with metal anodes using a top‐down framework. It begins with NASICON fundamentals, elucidates anode‐induced failure mechanisms, surveys advanced characterization strategies to understand them, summarizes mitigation approaches, and concludes with a ...
Jiaqi Xu   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy